| NOC |
Report |
Q2 2026 Adjusted EPS |
BEAT |
pred ~$7.00 vs. cons ~$6.83 |
MEDIUM |
| NOC |
Report |
Q2 2026 Revenue |
BEAT |
pred ~$10.92B vs. cons ~$10.80B |
MEDIUM |
| NOC |
Report |
Q2 2026 Free Cash Flow |
MISS |
pred ~-$100M vs. cons ~$300M |
MEDIUM |
| NOC |
Guide |
FY2026 Adjusted EPS guidance |
LOWER |
guide ~$27.65 (midpoint, unchanged $27.40-$27.90) vs. cons ~$27.93 (FY2026) |
MEDIUM |
| NOC |
Guide |
FY2026 Free Cash Flow guidance |
UNCHANGED |
guide ~$3.3B (midpoint, unchanged $3.1-$3.5B) vs. cons ~$3.3B (FY2026) |
MEDIUM |
| NOC |
Guide |
FY2026 Sales guidance |
UNCHANGED |
guide ~$43.75B (midpoint, unchanged $43.5-$44.0B) vs. cons ~$43.8B (FY2026) |
HIGH |
| NOC |
Guide |
Space Systems segment margin commentary |
UNCHANGED |
guide ~11% margin (reiterated) vs. cons ~11% (FY2026) |
LOW |
| NOC |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
MEDIUM |
| NOC |
Return |
5-day cumulative residual |
+0.4% (FADE) |
An EPS/revenue beat should spark a short-covering relief bounce given deeply oversold conditions and already-slashed sell-side targets, but the FY2026 EPS guide (~$27.65 midpoint) sits below Street consensus (~$27.93), so analysts likely trim out-year numbers toward guidance even after a headline beat — the same dynamic that turned Q1's beat into a ~19% post-print decline via FCF/EAC concerns. Continued B-21 capex ramp and uncertain H2 cash conversion keep FCF-driven revision risk alive, causing the initial pop to fade over the week rather than follow through. |
LOW |